MedTrace Logo

F573 Ia Clinical Trial

NCT04820049 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-11-08

No results posted yet for this study

Summary

Tolerance and PK study of F573

Conditions

  • Tolerance
  • Pharmacokinetic

Interventions

DRUG

F573

F573 for injection

OTHER

Placebo

Water for injection

Sponsors & Collaborators

  • Beijing Continent Pharmaceutical Co, Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2022-08-02
Completion
2022-11-06

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04820049 on ClinicalTrials.gov